Secondary AML
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies (NCT00145613) | St. Jude Children's Research Hospital | 2003-06-01 |
| EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML (NCT02533115) | Jazz Pharmaceuticals |
Track Secondary AML automatically
Every clearance here is in the API, with alerts when new ones post.